Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and
July 2023 - Molecular Pathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Molecular Pathology.
Genetic Testing to Enhance Multiple Myeloma Treatment - Insights
Multiple myeloma is the second most common blood cancer, but most people haven’t heard of it until they or someone they know is diagnosed with the disease. March is Myeloma Action Month—a time to focus attention on the fight against...
Zooming in on Cancer Suspects - Insights
Genetic testing is like security-camera video footage of a break-in, providing essential clues to identify a culprit. In certain cancers, the "culprit" might be a rearrangement in a person's DNA, which genomic testing can capture. Mayo...
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Autoimmune profile updates - Insights
Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from...
Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and
Operational updates - Insights
The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.
Dietrich Matern, M.D., Ph.D., Division Chair of Laboratory Genetics in the Department of Laboratory Medicine and Pathology in Rochester, Minnesota, has been appointed as a new director on the board of the American College of Medical...
numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance...